Development of cellular immune response after infant pneumococcal conjugate vaccinations.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 06 Jun 2010 Status changed from planning to completed as reported by Netherlands Trial Register record.
- 07 May 2009 Status changed from not stated to planning.
- 07 May 2009 New trial record